The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria

OBJECTIVES: To investigate the necessity of stratifying patients in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center (MSKCC) criteria in a real-world population of patients with metastatic renal cell carcinoma. PATIENTS AND METHODS: We retrospectively analyzed 234 consecutiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamada, Satoshi, Iguchi, Taro, Yasuda, Sayaka, Kato, Minoru, Yamasaki, Takeshi, Nakatani, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021254/
https://www.ncbi.nlm.nih.gov/pubmed/29963234
http://dx.doi.org/10.18632/oncotarget.25554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021254/
https://www.ncbi.nlm.nih.gov/pubmed/29963234
http://dx.doi.org/10.18632/oncotarget.25554

Ejemplares similares